Search

Your search keyword '"Patil, Deepak Y."' showing total 237 results
Start Over Author "Patil, Deepak Y."
237 results on '"Patil, Deepak Y."'

6. Comparative immune profiling in survivors of the 2023 Nipah outbreak in Kerala state, India.

Author

Sahay, Rima R., Palav, Harsha C., Shete, Anita M., Patil, Deepak Y., Mohandas, Sreelekshmy, Radhakrishnan, Chandni, Shihabudheen, P., Kumar, Anoop, Moorkoth, Anitha Puduvail, Mohite, Nandan, Gurav, Pranay, Pullor, Niyas K., Jain, Rajlaxmi, Joshi, Yash, Ramakrishnan, Lathika Velichapat, Gupta, Nivedita, Patel, Vainav, and Yadav, Pragya D.

Subjects
NIPAH virus, TREATMENT effectiveness, CELL populations, SYMPTOMS, REGULATORY T cells, LYMPHOPENIA
Abstract

Immune profiling of Nipah virus (NiV) infection survivors is essential for advancing our understanding of NiV pathogenesis, improving diagnostic and therapeutic strategies, and guiding public health efforts to prevent future outbreaks. There is currently limited data available on the immune response to NiV infection. We aimed to elucidate the specific immune mechanisms involved in protection against NiV infection by analyzing the immune profiles of survivors of the Nipah outbreak in Kerala, India 2023. Immune cell populations were quantified and compared between survivors (up to 4 months post onset day of illness) and healthy controls. Statistical analysis was performed to explore associations between immune profiles and clinical outcomes. Immune signatures common to all three cases were: a heretofore undescribed persistent lymphopenia including the CD4+ Treg compartment with the relative expansion of memory Tregs; trends indicative of global leukopenic modulation were observed in monocytes and granulocytes including an expansion of putatively immunosuppressive low‐density granulocytes described recently in the context of severe COVID‐19; altered mucosal homing with respect to integrin beta‐7 (ITGB7) expressing subsets; increased mobilization of activated T‐cells (CD4+ and CD8+) and plasmablasts in the early phase of infection. Comparative analysis based on clinical presentation and outcome yielded lower initial viremia, increased activated T‐cell responses, expanded plasmablasts, and restoration of ITGB7 expressing CD8+ T‐cells as possible protective signatures. This longitudinal study delineates putative protective signatures associated with milder NiV disease. It emphasizes the need for the development of immunotherapeutic interventions such as monoclonal antibodies to blunt early viremia and ameliorate pathogenesis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Construction of an Immunoinformatics-Based Multi-Epitope Vaccine Candidate targeting Kyasanur Forest Disease Virus

Author

Kasibhatla, Sunitha M., primary, Rajan, Lekshmi S., additional, Shete, Anita M., additional, Jani, Vinod, additional, Patil, Savita, additional, Joshi, Yash, additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, Mohandas, Sreelekshmy, additional, Majumdar, Triparna, additional, Sonavane, Uddhavesh, additional, Joshi, Rajendra, additional, and Yadav, Pragya D., additional

Published
2024
Full Text
View/download PDF

9. A rare case of Chandipura virus infection with haemorrhagic complications from Gujarat, India

Author

Punasanvala, Pranav, primary, Sahay, Rima R., additional, Chandegara, Hiren, additional, Patil, Deepak Y., additional, Shete, Anita M., additional, Balachandran, Chandhu, additional, Patel, Vipul, additional, Bondre, Vijay, additional, Rustam, Rizwana, additional, Patel, Karma, additional, Majumdar, Triparna, additional, Shah, Kavya, additional, Patil, Savita, additional, Sakhare, Kunal, additional, Solanki, Jayesh, additional, Gawande, Pranita, additional, Kumari, Vaishnavi, additional, and Yadav, Pragya D., additional

Published
2023
Full Text
View/download PDF

10. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019

Author

Munivenkatappa, Ashok, primary, Yadav, Pragya D., additional, Sahay, Rima R., additional, SK, Kiran, additional, Shete, Anita M., additional, Patil, Deepak Y., additional, Mohandas, Sreelekshmy, additional, Jain, Rajlaxmi, additional, Patil, Savita, additional, Sinha, Diamond P., additional, and Jayaswamy, Manjunatha M., additional

Published
2023
Full Text
View/download PDF

11. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques

Author

Yadav, Pragya D., Ella, Raches, Kumar, Sanjay, Patil, Dilip R., Mohandas, Sreelekshmy, Shete, Anita M., Vadrevu, Krishna M., Bhati, Gaurav, Sapkal, Gajanan, Kaushal, Himanshu, Patil, Savita, Jain, Rajlaxmi, Deshpande, Gururaj, Gupta, Nivedita, Agarwal, Kshitij, Gokhale, Mangesh, Mathapati, Basavaraj, Metkari, Siddhanath, Mote, Chandrashekhar, Nyayanit, Dimpal, Patil, Deepak Y., Sai Prasad, B. S., Suryawanshi, Annasaheb, Kadam, Manoj, Kumar, Abhimanyu, Daigude, Sachin, Gopale, Sanjay, Majumdar, Triparna, Mali, Deepak, Sarkale, Prasad, Baradkar, Shreekant, Gawande, Pranita, Joshi, Yash, Fulari, Sidharam, Dighe, Hitesh, Sharma, Sharda, Gunjikar, Rashmi, Kumar, Abhinendra, Kalele, Kaumudi, Srinivas, Vellimedu K., Gangakhedkar, Raman R., Ella, Krishna M., Abraham, Priya, Panda, Samiran, and Bhargava, Balram

Published
2021
Full Text
View/download PDF

12. Clinico‐epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023.

Author

AS, Anoop Kumar, Sahay, Rima R., Radhakrishnan, Chandni, P, Shihabudheen, Kandath, Sathishkumar, Patil, Deepak Y., Shete, Anita M., M, Shamsudheen, Ramakrishnan, Gayathri, Moorkoth, Anitha Puduvail, Gupta, Nivedita, Yadav, Pragya D., Godbole, Sheela, Ramakrishnan, Lathika Velichapat, Vadekkandiyil, Shameer, Ekkalayil, Danish, V, Nithasha, Balakrishnan, Anukumar, Pullor, Niyas K., and Asokan, Neelakandhan

Subjects
NIPAH virus, VIRUS diseases, ADULT respiratory distress syndrome, SYMPTOMS, GENOMICS
Abstract

India experienced its sixth Nipah virus (NiV) outbreak in September 2023 in the Kozhikode district of Kerala state. The NiV is primarily transmitted by spillover events from infected bats followed by human‐to‐human transmission. The clinical specimens were screened using real‐time RT‐PCR, and positive specimens were further characterized using next‐generation sequencing. We describe here an in‐depth clinical presentation and management of NiV‐confirmed cases and outbreak containment activities. The current outbreak reported a total of six cases with two deaths, with a case fatality ratio of 33.33%. The cases had a mixed presentation of acute respiratory distress syndrome and encephalitis syndrome. Fever was a persistent presentation in all the cases. The Nipah viral RNA was detected in clinical specimens until the post‐onset day of illness (POD) 14, with viral load in the range of 1.7–3.3 × 104 viral RNA copies/mL. The genomic analysis showed that the sequences from the current outbreak clustered into the Indian clade similar to the 2018 and 2019 outbreaks. This study highlights the vigilance of the health system to detect and effectively manage the clustering of cases with clinical presentations similar to NiV, which led to early detection and containment activities. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019.

Author

Munivenkatappa, Ashok, Yadav, Pragya D., Sahay, Rima R., SK, Kiran, Shete, Anita M., Patil, Deepak Y., Mohandas, Sreelekshmy, Jain, Rajlaxmi, Patil, Savita, Sinha, Diamond P., and Jayaswamy, Manjunatha M.

Subjects
DENGUE viruses, CHIKUNGUNYA virus, DENGUE hemorrhagic fever, NUCLEOTIDE sequencing, SEQUENCE analysis, CHIKUNGUNYA
Abstract

In this study, we carried out an investigation of Kyasanur Forest Disease (KFD) suspected human cases reported in Karnataka state, India from December 2018 to June 2019. The clinical samples of KFD suspected cases (n = 1955) from 14 districts of Karnataka were tested for KFD using real-time RT-PCR and IgM ELISA. Further, the KFD-negative samples were tested for IgM antibodies against dengue and chikungunya viruses. Monkey samples (n = 276) and tick pools (n = 11582) were also screened using real-time RT-PCR. KFD-positive samples were further analysed using next-generation sequencing along with clinico-epidemiological analysis. Of all, 173 (8.8%) cases tested positive for KFD either by real-time RT-PCR (n = 124), IgM ELISA (n = 53) or both tests (n = 4) from seven districts. Among KFD-negative cases, IgM antibody positivity was observed for dengue (2.6%), chikungunya (5.8%), dengue and chikungunya coinfection (3.7%). KFD cases peaked in January 2019 with fever, conjunctivitis, and myalgia as the predominant symptoms and a mortality of 4.6%. Among confirmed cases, 41% received a single dose and 20% received two doses of the KFD vaccine. Of the seven districts with KFDV positivity, Shivamogga and Hassan districts reported KFD viral RNA positivity in humans, monkeys, and ticks. Sequencing analysis of 2019 cases demonstrated a difference of less than 1.5% amino acid compared to prototype KFDV. Although the KFD has been endemic in many districts of Karnataka state, our study confirms the presence of KFDV for the first time in two new districts, i.e. Hassan and Mysore. A comparative analysis of KFDV infection among the KFD-vaccinated and non-vaccinated populations demonstrated an insignificant difference. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. First detection of Varicella Zoster Virus clade 9 cases in India during mpox surveillance

Author

Kumar, Abhinendra, primary, Rajan, Lekshmi S., additional, Sabarinath PS, Kannan, additional, Shete, Anita M., additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, Ingole, Nayana, additional, K, Kaveri, additional, Padinakarai, Anupama Cherayi, additional, GB, Shantala, additional, Shastri, Jayanthi, additional, Padukone, Shashiraja, additional, Joshi, Yash, additional, Patil, Savita, additional, Majumdar, Triparna, additional, Verma, Ajay, additional, Yemul, Jyoti, additional, Shende, Nandini, additional, Kumari, Vaishnavi, additional, Vedpathak, Pratiksha, additional, Sathe, Shubhangi, additional, Gawande, Pranita, additional, and Yadav, Pragya D., additional

Published
2023
Full Text
View/download PDF

16. A fatal case of Crimean‐Congo hemorrhagic fever from Kutch, Gujarat, India 2023.

Author

Sahay, Rima R., Patil, Deepak Y., Shete, Anita M., Nayak, Sarita, Parikh, Tejash M., Waghmare, Vishal T., Patel, Amit, Shah, Anand, Upadhyay, Kamlesh, Solanki, Jayesh, Kanani, Amit, and Yadav, Pragya D.

Subjects
HEMORRHAGIC fever, FATIGUE (Physiology), TICK-borne diseases, FEVER, MYALGIA
Abstract

This article discusses a case of Crimean-Congo hemorrhagic fever (CCHF) in Kutch, Gujarat, India. CCHF is a tick-borne disease that affects humans and animals. The article provides detailed information about a 51-year-old male patient who had contact with livestock and exhibited symptoms such as fever, headache, myalgia, and fatigue. Despite treatment, the patient developed multiorgan dysfunction and ultimately died from the infection. The article emphasizes the importance of timely diagnosis, isolation, and treatment for CCHF, as well as the need for awareness and preventive measures in at-risk communities. [Extracted from the article]

Published
2023
Full Text
View/download PDF

17. An imported case of fatal encephalitis associated with mpox virus infection, India, July 2022

Author

Yadav, Pragya D., primary, Vasu, Meenakshy, additional, Abubaker, Fazil, additional, Sahay, Rima R., additional, Reghukumar, Aravind, additional, Krishnan, Anukumar Bala, additional, Prabha, Kavya, additional, Papu, Asha Konipparambil, additional, Gopalakrishnan, Lakshmi Geetha, additional, Mundangalam, Nizamuddin, additional, Siddiq, Aboobaker, additional, Patil, Deepak Y., additional, Shete, Anita M., additional, Abraham, Priya, additional, Prasad, Anoop Rajendra, additional, Thavakara Koolothuvalappil, Anoop, additional, and Karunakaran, Kavya, additional

Published
2023
Full Text
View/download PDF

18. Persistence of infectious monkey pox virus on the surfaces of isolation ward in a hospital setting, India

Author

Sahay, Rima R., primary, Relhan, Vineet, additional, Shete, Anita M., additional, Patil, Deepak Y., additional, Kumar, Lekshmi P., additional, Kaur, Aneet, additional, Majumdar, Triparna, additional, Agarwal, Deeksha, additional, Gawande, Pranita, additional, Lalmuanpuii, Gaby, additional, Yemul, Jyoti, additional, Bahadur, Amar, additional, Vedpathak, Pratiksha, additional, Guglani, Aditi, additional, MR, Pavani Gowda, additional, Mali, Deepak, additional, Dighe, Hitesh, additional, Sarkale, Prasad, additional, Kumar, Abhinav, additional, Jain, Rajlaxmi, additional, Sahoo, Bijaylaxmi, additional, Kumar, Suresh, additional, and Yadav, Pragya D., additional

Published
2023
Full Text
View/download PDF

19. A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022

Author

Patil, Deepak Y., primary, George, Sandhya, additional, Sahay, Rima R., additional, Chenayil, Shubin, additional, Shete, Anita M., additional, Bhaskaramenon, Sindhu C., additional, Anish, Thekkumkara Surendran, additional, Jain, Rajlaxmi, additional, Nazeer, Fathima Abdul, additional, John, Reena, additional, Joshi, Yash, additional, Sivaprasad, R., additional, Waghmare, Priyanka, additional, Ray, Shilpa, additional, Balakrishnan, Swapna, additional, Kumari, Vaishnavi, additional, Sathe, Shubhangi, additional, and Yadav, Pragya D., additional

Published
2023
Full Text
View/download PDF

21. Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA.

Author

Shete, Anita M., Patil, Deepak Y., Jain, Rajlaxmi, Sahay, Rima R., Chenayil, Shubin, Mohandas, Sreelekshmy, and Yadav, Pragya D.

Subjects
MONKEYPOX, IMMUNOGLOBULIN G, NUCLEOTIDE sequencing, RAPID response teams, IMMUNOGLOBULINS
Abstract

However, still there is limited sero-surveillance in mpox endemic areas.[6] The previous study has suggested that detectable levels of antibodies can be detected within 7-14 days after mpox infection.[5] However, there is scanty data available on the persistence of the antibodies amongst mpox cases. Since the 1970s, monkeypox (mpox) has been mostly observed in rural areas of Central and West Africa near tropical rainforests. The mpox immunoglobulin M (IgM) and immunoglobulin G (IgG) enzyme-linked immunoassay (ELISA) were developed and standardized to determine the antibody levels in mpox cases. Recently, mpoxv A29L protein-specific monoclonal antibody-based antigens detection assays has shown promising results for rapid antigen detection of mpox infection.[5] The mpox-specific antibody test allows serological diagnosis in cases of suspected monkeypox. [Extracted from the article]

Published
2023
Full Text
View/download PDF

22. Needle‐free injection system delivery of ZyCoV‐D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS‐CoV‐2

Author

Yadav, Pragya D., primary, Kumar, Sanjay, additional, Agarwal, Kshitij, additional, Jain, Mukul, additional, Patil, Dilip R., additional, Maithal, Kapil, additional, Mathapati, Basavaraj, additional, Giri, Suresh, additional, Mohandas, Sreelekshmy, additional, Shete, Anita, additional, Sapkal, Gajanan, additional, Patil, Deepak Y., additional, Dey, Ayan, additional, Chandra, Harish, additional, Deshpande, Gururaj, additional, Gupta, Nivedita, additional, Abraham, Priya, additional, Kaushal, Himanshu, additional, Sahay, Rima R., additional, Tripathy, Anuradha, additional, Nyayanit, Dimpal, additional, Jain, Rajlaxmi, additional, Kumar, Abhimanyu, additional, Sarkale, Prasad, additional, Baradkar, Shreekant, additional, Rajanathan, Chozhavel, additional, Raju, Hari Prasad, additional, Patel, Satish, additional, Shah, Niraj, additional, Dwivedi, Pankaj, additional, and Singh, Dharmendra, additional

Published
2023
Full Text
View/download PDF

23. Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage

Author

Shete, Anita M., primary, Yadav, Pragya D., additional, Kumar, Abhinendra, additional, Patil, Savita, additional, Patil, Deepak Y., additional, Joshi, Yash, additional, Majumdar, Triparna, additional, Relhan, Vineet, additional, Sahay, Rima R., additional, Vasu, Meenakshy, additional, Gawande, Pranita, additional, Verma, Ajay, additional, Kumar, Arbind, additional, Dhakad, Shivram, additional, Krishnan, Anukumar Bala, additional, Chenayil, Shubin, additional, Kumar, Suresh, additional, and Abraham, Priya, additional

Published
2023
Full Text
View/download PDF

24. Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months

Author

Sahay, Rima R., primary, Yadav, Pragya D., additional, Nandapurkar, Ashok, additional, Dhawde, Rutuja, additional, Suryawanshi, Annasaheb, additional, Patil, Deepak Y., additional, Shete, Anita M., additional, Sapkal, Gajanan N., additional, Kulkarni, Milind, additional, Gurav, Yogesh K., additional, Deshpande, Gururaj R., additional, Ghodke, Jagdevi S., additional, Jain, Rajlaxmi, additional, Hawale, Raj, additional, Kalele, Kaumudi, additional, Yemul, Jyoti, additional, Gawande, Pranita, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

25. Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India

Author

Shastri, Jayanthi, primary, Yadav, Pragya D., additional, Agrawal, Sachee, additional, Shete, Anita M., additional, Nyayanit, Dimpal A., additional, Parikh, Swapneil, additional, Gomare, Mangala, additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, Dudhmal, Manisha, additional, and Kadam, Neelam, additional

Published
2022
Full Text
View/download PDF

26. Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern

Author

Dighe, Hitesh, primary, Sarkale, Prasad, additional, Patil, Deepak Y., additional, Mohandas, Sreelekshmy, additional, Shete, Anita M., additional, Sahay, Rima R., additional, Lakra, Rajen, additional, Patil, Savita, additional, Majumdar, Triparna, additional, Gawande, Pranita, additional, Yemul, Jyoti, additional, Vedpathak, Pratiksha, additional, and Yadav, Pragya D., additional

Published
2022
Full Text
View/download PDF

27. Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022

Author

Relhan, Vineet, primary, Sahay, Rima R., additional, Shete, Anita M., additional, Yadav, Pragya D., additional, Sahoo, Bijaylaxmi, additional, Patil, Deepak Y., additional, Kumar, Suresh, additional, Premachandran Syamaladevi, Kannan Sabarinath, additional, Dar, Lalit, additional, Mohandas, Sreelekshmy, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

28. First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022

Author

Yadav, Pragya D., primary, Reghukumar, Aravind, additional, Sahay, Rima R., additional, K, Sudeep, additional, Shete, Anita M., additional, Raman, Aruna, additional, VK, Pramod, additional, Abraham, Priya, additional, Benson, Reshma, additional, SM, Sarin, additional, Mohandas, Sreelekshmy, additional, Patil, Deepak Y., additional, Kumar, Abhinendra, additional, Gupta, Nivedita, additional, George, Anuja Elizabeth, additional, Vijay, Neetu, additional, U, Anuja, additional, Suresh, Manjusree, additional, A, Ramiz Raja, additional, Sapkal, Gajanan N, additional, Ravindranath, Manasi, additional, Sreenivasan, Sreenath, additional, James, Preethi, additional, and MK, Shaj, additional

Published
2022
Full Text
View/download PDF

29. Crimean-Congo hemorrhagic fever in migrant worker returning from Oman to India, 2016

Author

Yadav, Pragya D., Thacker, Sachin, Patil, Deepak Y., Jain, Rajlaxmi, and Mourya, Devendra T.

Subjects
Migrant labor -- Research, Hemorrhagic fevers -- Risk factors, Health
Abstract

Increased international travel has led to the global spread of numerous diseases (1). One of these diseases, Crimean-Congo hemorrhagic fever (CCHF), has affected persons in >20 countries in Africa, Asia, [...]

Published
2017
Full Text
View/download PDF

31. Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage

Author

Shete, Anita M., primary, Yadav, Pragya D., additional, Kumar, Abhinendra, additional, Patil, Savita, additional, Patil, Deepak Y., additional, Joshi, Yash, additional, Majumdar, Triparna, additional, Relhan, Vineet, additional, Sahay, Rima R., additional, Vasu, Meenakshy, additional, Gawande, Pranita, additional, Verma, Ajay, additional, Kumar, Arbind, additional, Dhakad, Shivram, additional, Krishnan, Anukumar Bala, additional, Chenayil, Shubin, additional, Kumar, Suresh, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

32. A fatal case of monkeypox virus infection from Kerala India 2022

Author

Yadav, Pragya D., primary, Vasu, Meenakshy, additional, Abubaker, Fazil, additional, Sahay, Rima R., additional, Reghukumar, Aravind, additional, Krishnan, Anukumar Bala, additional, Prabha, Kavya, additional, Papu, Asha Konipparambil, additional, Gopalakrishnan, Lakshmi Geetha, additional, Mundangalam, Nizamuddin, additional, Siddiq, Aboobaker, additional, Patil, Deepak Y., additional, Shete, Anita M., additional, Abraham, Priya, additional, Prasad, Anoop Rajendra, additional, TK, Anoop, additional, and Karunakaran, Kavya, additional

Published
2022
Full Text
View/download PDF

35. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021

Author

Yadav, Pragya D., primary, Sahay, Rima R., additional, Agrawal, Sachee, additional, Shete, Anita, additional, Adsul, Balkrishna, additional, Tripathy, Srikanth, additional, Nyayanit, Dimpal A., additional, Manrai, Manish, additional, Patil, Deepak Y., additional, Kumar, Sanjay, additional, Marwah, Vikas, additional, Sapkal, Gajanan N., additional, Shastri, Jayanthi, additional, Viswanathan, Rajlakshmi, additional, Pandit, Priyanka, additional, Mishra, Yogendra, additional, Chavan, Smita, additional, Joshi, Yash, additional, Kumar, T Ajai, additional, Majumdar, Triparna, additional, Kumar, Abhinendra, additional, Patil, Savita, additional, Munshi, Renuka, additional, Desai, Unnati, additional, Kaushal, Himanshu, additional, Suryawanshi, Annasaheb, additional, Dudhmal, Manisha, additional, Gawande, Pranita, additional, Jain, Rajlaxmi, additional, Waghmare, Ashwini, additional, Kalele, Kaumudi, additional, Vedpathak, Pratiksha, additional, Yemul, Jyoti, additional, Bodke, Poonam, additional, Kore, Tejashri, additional, Kakrani, A.L., additional, Athavale, Prachi, additional, Suryawanshi, Poonam, additional, Patsute, Sudhir, additional, Padbidri, Vikram, additional, Awate, Pradip, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

37. Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination

Author

Yadav, Pragya D., primary, Sapkal, Gajanan N., additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, Agrawal, Sachee, additional, Adsul, Balkrishna, additional, Tripathy, Srikanth, additional, Deshpande, Gururaj R., additional, Nyayanit, Dimpal A., additional, Shete, Anita M., additional, Manraie, Manish, additional, Kumar, Sanjay, additional, Shastri, Jayanthi, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

38. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees

Author

Yadav, Pragya D., primary, Sapkal, Gajanan N., additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, Deshpande, Gururaj R., additional, Jain, Rajlaxmi, additional, Nyayanit, Dimpal A., additional, Shete, Anita M., additional, Suryawanshi, Annasaheb, additional, Nandapurkar, Ashok, additional, Gurav, Yogesh K., additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

40. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern

Author

Yadav, Pragya D., primary, Sapkal, Gajanan N., additional, Sahay, Rima R., additional, Potdar, Varsha A., additional, Deshpande, Gururaj R., additional, Patil, Deepak Y., additional, Nyayanit, Dimpal A., additional, Shete, Anita M., additional, Shastri, Jayanthi, additional, Awate, Pradip, additional, Malhotra, Bharti, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

41. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model

Author

Yadav, Pragya D., primary, Mohandas, Sreelekshmy, additional, Shete, Anita M., additional, Nyayanit, Dimpal A., additional, Gupta, Nivedita, additional, Patil, Deepak Y., additional, Sapkal, Gajanan N., additional, Potdar, Varsha, additional, Kadam, Manoj, additional, Kumar, Abhimanyu, additional, Kumar, Sanjay, additional, Suryavanshi, Deepak, additional, Mote, Chandrashekhar S., additional, Abraham, Priya, additional, Panda, Samiran, additional, and Bhargava, Balram, additional

Published
2022
Full Text
View/download PDF

42. Serosurvey for Nipah virus in bat population of southern part of India

Author

Gokhale, Mangesh, Sudeep, A.B., Mathapati, Basavaraj, Balasubramanian, R., Ullas, P.T., Mohandas, Sreelekshmy, Patil, Dilip R., Shete, Anita M., Gopale, Sanjay, Sawant, Pradeep, Jain, Rajlaxmi, Holeppanavar, Manjunath, Suryawanshi, Annasaheb T., Chopade, Ganesh, Dhaigude, Sachin, Patil, Deepak Y., Mourya, Devendra T., and Yadav, Pragya D.

Published
2022
Full Text
View/download PDF

44. Detection and isolation of SARS‐CoV‐2 Eta variant from the international travelers and local residents of India

Author

Yadav, Pragya D., primary, Nyayanit, Dimpal A., additional, Gupta, Nivedita, additional, Shastri, Jayanthi, additional, Sahay, Rima R., additional, Patil, Deepak Y., additional, M. Shete, Anita, additional, Razdan, Alpana, additional, Agrawal, Sachee, additional, Kumar, Abhinendra, additional, Majumdar, Triparna, additional, Patil, Savita, additional, Sarkale, Prasad, additional, Baradkar, Shreekant, additional, Dudhmal, Manisha, additional, Kaur, Harmanmeet, additional, and Aggarwal, Neeraj, additional

Published
2022
Full Text
View/download PDF

45. Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine

Author

Sapkal, Gajanan, primary, Kant, Rajni, additional, Dwivedi, Gaurav, additional, Sahay, Rima R, additional, Yadav, Pragya D, additional, Deshpande, Gururaj R, additional, Singh, Rajeev, additional, Nyayanit, Dimpal A, additional, Patil, Deepak Y, additional, Shete-Aich, Anita M, additional, Zaman, Kamran, additional, Chaudhari, Anil K, additional, Gupta, Nivedita, additional, Panda, Samiran, additional, Abraham, Priya, additional, and Bhargava, Balram, additional

Published
2022
Full Text
View/download PDF

46. Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens

Author

Yadav, Pragya D., primary, Gupta, Nivedita, additional, Potdar, Varsha, additional, Mohandas, Sreelekshmy, additional, Sahay, Rima R., additional, Sarkale, Prasad, additional, Shete, Anita M., additional, Razdan, Alpana, additional, Patil, Deepak Y., additional, Nyayanit, Dimpal A., additional, Joshi, Yash, additional, Patil, Savita, additional, Majumdar, Triparna, additional, Dighe, Hitesh, additional, Malhotra, Bharti, additional, Shastri, Jayanthi, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

47. Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic

Author

Yadav, Pragya D., primary, Sahay, Rima R., additional, Balakrishnan, Anukumar, additional, Mohandas, Sreelekshmy, additional, Radhakrishnan, Chandni, additional, Gokhale, Mangesh D., additional, Balasubramanian, R., additional, Abraham, Priya, additional, Gupta, Nivedita, additional, Sugunan, A. P., additional, Khobragade, Rajan, additional, George, Kalpana, additional, Shete, Anita, additional, Patil, Savita, additional, Thankappan, Ullas Padinjaremattathil, additional, Dighe, Hitesh, additional, Koshy, Jijo, additional, Vijay, Vivek, additional, Gayathri, R., additional, Kumar, P. Jayesh, additional, Rahim, Asma, additional, Naveen, A., additional, Nair, Sarala, additional, Rajendran, V. R., additional, Jayasree, V., additional, Majumdar, Triparna, additional, Jain, Rajlaxmi, additional, Viswanathan, Prasanth, additional, Patil, Deepak Y., additional, Kumar, Abhinendra, additional, Nyayanit, Dimpal A., additional, Sarkale, Prasad, additional, Waghmare, Ashwini, additional, Baradkar, Shrikant, additional, Gawande, Pranita, additional, Bodke, Poonam, additional, Kalele, Kaumudi, additional, Yemul, Jyoti, additional, Dhaigude, Sachin, additional, Holepannawar, Manjunath, additional, Gopale, Sanjay, additional, Chopade, Ganesh, additional, Ray, Shilpa, additional, Waghmare, Priyanka, additional, Narayan, Jitendra, additional, Mathapati, Basavaraj, additional, Kadam, Manoj, additional, Kumar, Abhimanyu, additional, Suryawanshi, Annasaheb, additional, Jose, Beena Philomina, additional, Sivadas, Saritha, additional, Akash, N. P., additional, Vimisha, T. V., additional, and Keerthi, K. V., additional

Published
2022
Full Text
View/download PDF

50. An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens

Author

Yadav, Pragya D, primary, Gupta, Nivedita, additional, Potdar, Varsha, additional, Mohandas, Sreelekshmy, additional, Sahay, Rima R, additional, Sarkale, Prasad, additional, Shete, Anita M, additional, Razdan, Alpana, additional, Patil, Deepak Y, additional, Nyayanit, Dimpal A, additional, Joshi, Yash, additional, Patil, Savita, additional, Majumdar, Triparna, additional, Dighe, Hitesh, additional, Malhotra, Bharti, additional, Shastri, Jayanthi, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results